Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients
Keywords:
Depression, Elderly, Antidepressant drugs, Tricyclics, Sertraline, SSRI'sAbstract
CONTEXT: Most double-blind studies of efficacy and tolerability of sertraline as compared to tricyclics in the treatment of late-life major depression have used amitriptyline as a standard, leading to the inevitable conclusion that the former drug is better tolerated than the latter, with both being equally efficacious. OBJECTIVE: To compare the antidepressant efficacy and tolerability of sertraline (50 mg/day) and imipramine (150 mg/day) in the first 6 weeks of the treatment of major depression in the elderly. DESIGN: A randomized double-blind parallel study with 6 weeks of follow-up. SETTING: The psychogeriatric clinic at the Institute of Psychiatry, Hospital das Clínicas, Faculty of Medicine of the University of São Paulo. PARTICIPANTS: 55 severe and moderately depressed non-demented outpatients aged 60 years or more. INTERVENTION: Patients were assigned to sertraline 50 mg/day or imipramine 150 mg/day. MAIN MEASUREMENTS: CAMDEX interview. Psychiatric diagnosis followed the guidelines for "Major Depressive Episode" according to DSM-IV criteria. Severity of symptoms was evaluated using the "CGI" and "MADRS" scales. Cognitive state was assessed using the Mini-Mental State Examination. Side effects were assessed using the "Safetee-Up" schedule. RESULTS: Both groups had a significant decrease in depressive symptoms according to the MADRS scores after 6 weeks of treatment (P = 0.01). No significant differences between groups were detected regarding treatment outcome (t = 0.4; P = 0.7). Although the dropout rate was greater in the imipramine group, the overall tolerability among patients who completed the 6-week trial was similar in both test groups. CONCLUSIONS: Both sertraline and imipramine exhibited good efficacy and an acceptable side-effect profile for elderly depressed patients after 6 weeks of antidepressant treatment.
Downloads
References
Cohn CK, Shrivastava R, Mendels J, et al. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 1990;51(Suppl B):28-33.
Reimherr FW, Chouinard G, Cohn CK, et al. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 1990;51(Suppl B):18-27.
Finkel SI, Richter EM, Clary CM. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older. Int Psychogeriatr 1999;11:85-99.
Preskorn SH Recent pharmacological advances in antidepressant therapy for the elderly. Am J Med 1993;94(Suppl 5A):2S-12S.
Bingefors K, Isacson D, Knorring LV, et al. Antidepressant-treated patients in ambulatory care: mortality during a nine-year period after first treatment. Br J Psychiatry 1996;169(5):647-54.
Knegtering H, Eijck M, Huijsman A. Effects of antidepressants on cognitive functioning of elderly patients: a review. Drugs Aging 1994;5(3):192-9.
Oxman TE. Antidepressants and cognitive impairment in the elderly. J Clin Psychiatry 1996;57(Suppl 5):38-44.
Roose SP, Glassman AH, Attia E, et al. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994;151(12):1735-9.
Heeren TJ, Derksen P, van Heycop Tem Ham BF, et al. Treatment, outcome and predictors of response in elderly depressed in patients. Br J Psychiatry 1997;170:436-40.
Rubin EH, Kinscherf DA, Wehrman AS, et al. Response to treatment of depression in the old and very old. J Geriatr Psychiatry Neurol 1991;4:65-70.
Zubenko GS, Mulsant BH, Rifai AH, et al. Impact of acute psychiatric treatment on major depression in late life and prediction of response. Am J Psychiatry 1994;151,984-7.
Mittmann N, Herrmann N, Einarson TR, et al. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. J Affect Dis 1997;46:191-217.
Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fourth Edition. Washington D.C.: American Psychiatric Association; 1994.
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
Dratcu L, da Costa Ribeiro L, Calil HM. Depression assessment in Brazil. The first application of the Montgomery-Asberg Depression Rating Scale. Br J Psychiatry 1987;150:797-800.
Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
Levine J, Scholer NR. Strategies for analyzing side effect data from Safetee: a workshop held Fall 1985 in Rockville, Maryland. Psychopharmacol Bull 1986;22(2):343-357.
Schatzberg AF. Treatment of chronic major depression: double-blind trial of sertraline and imipramine. XX CINP, Melbourne, Australia, 23-27 June 1996.
